Search company, investor...
Aktana company logo


Founded Year



Series D | Alive

Total Raised


Last Raised

$30M | 3 yrs ago

About Aktana

Aktana develops a decision support platform for the global life sciences industry. Its proprietary platform harnesses algorithms to enable marketing and sales teams to coordinate and optimize multichannel engagement with healthcare professionals. Committed to customer success, Aktana supports 100+ brands worldwide to capitalize on data investments, drive productivity, and continually enhance campaign performance.

Headquarters Location

207 Powell Street 8th Floor

San Francisco, California, 94102,

United States


Compete with Aktana?

Ensure that your company and products are accurately represented on our platform.

Aktana's Products & Differentiators

    Aktana Platform

    The foundation of the Atkana solution. A stable and secure platform that integrates with the full range of data sources, analytics, and marketing technology to amplify the value of your AI and analytics.

Aktana Patents

Aktana has filed 15 patents.

The 3 most popular patent topics include:

  • Classification algorithms
  • Email
  • Free instant messaging clients
patents chart

Application Date

Grant Date


Related Topics




Market segmentation, Market research, Marketing strategy, Marketing, Bridge systems


Application Date


Grant Date



Related Topics

Market segmentation, Market research, Marketing strategy, Marketing, Bridge systems



Latest Aktana News

98% of Pharmaceutical Executives Agree on Importance of Omnichannel as Half of Companies Are Not Optimizing Physician Engagement across Touchpoints, Study Finds

Dec 6, 2022

December 06, 2022 07:00 AM Eastern Standard Time SAN FRANCISCO--( BUSINESS WIRE )-- Aktana , the leader in intelligent customer engagement for the global life sciences industry, today reveals striking results from a new study, “The State of Omnichannel HCP Engagement in Pharma: Where the Industry Stands in 2022.” In DHC Group’s survey of 50 industry executives across digital, brand marketing, field sales, and data analytics, 98% found omnichannel strategy to be “very important” while more than half of these companies say they are not yet optimizing HCP engagement across touchpoints. The gap suggests commercial models are changing, but gradually. “After decades of a go-to-market approach defined by best-guess strategies and appealing to physicians as a monolithic group, we’re finally flipping the script,” said Derek Choy, president of Aktana. “Today, it’s a strategic imperative for brands to transform the HCP experience into a seamless, cross-channel journey that’s personalized to a segment of one. With so many more options for engagement, organizations also need a scalable way to prioritize actions with the highest impact, refine strategies and focus valuable resources where they’ll deliver the greatest ROI. None of this is possible without AI.” Survey respondents indicated a few key challenges to omnichannel success. These include: Data and Technology Integration – 45% attributed challenges to complexities integrating and managing data People, Structure & Culture – 54% noted the inability to influence change management Enough Content – content continues to be a significant hurdle in brand marketing as 62% of respondents say they lack personalized content Single Platform Aligned with KPIs – nearly two-thirds report an unmet need for a single interface to manage and control omnichannel engagement across the organization Aktana’s modular solution enables commercial and medical teams from all-sized organizations to rapidly scale AI programs to personalize, optimize, and coordinate HCP engagement across channels and teams – allowing customers to grow sales by up to 15%. It has more than 300 deployments across 50+ use cases. More than half of the world's top-20 pharmaceutical companies – including Novartis, GSK, Novo Nordisk, Merck, Sanofi, and Pfizer – rely on Aktana to coordinate and optimize personalized omnichannel engagement with HCPs. Aktana’s Contextual Intelligence 360 platform is powered by the company’s next-generation Contextual Intelligence Engine , which uses AI-driven optimization to predict the value of all potential customer experiences, then prioritize and recommend Next Best Engagements. “In three to five years, I would hope that we've suddenly moved as an industry where AI isn't a buzzword. It's actually just baked into the mainstream of our go-to-market strategies because it's so essential,” said Novartis’ Global Director of Field Force AI Enablement Paul Thompson in the DHC report. In other news, Aktana was named a trailblazer in Everest Group’s assessment report, “ Life Sciences Commercial Analytics & AI Trailblazers. " The report assessed 47 startups primarily on core capabilities and market impact, looking specifically at domain focus, market buzz, product capabilities, and human capital (talent and leadership). Aktana received the highest overall rating. For a complete copy of the DHC Group study and to understand organizational readiness for omnichannel, please contact Lisa Barbadora ( ) or click here . Additional Information:

Aktana Frequently Asked Questions (FAQ)

  • When was Aktana founded?

    Aktana was founded in 2008.

  • Where is Aktana's headquarters?

    Aktana's headquarters is located at 207 Powell Street, San Francisco.

  • What is Aktana's latest funding round?

    Aktana's latest funding round is Series D.

  • How much did Aktana raise?

    Aktana raised a total of $112.76M.

  • Who are the investors of Aktana?

    Investors of Aktana include Starfish Ventures, dRx Capital, Norwest Venture Partners, CIBC Innovation Banking, Salesforce Accelerate and 3 more.

  • Who are Aktana's competitors?

    Competitors of Aktana include ZS Associates, XANT, EverString, Lattice Engines, ODAIA and 9 more.

  • What products does Aktana offer?

    Aktana's products include Aktana Platform and 4 more.

Compare Aktana to Competitors

Mapping Analytics

Mapping Analytics provides analytic and consulting services, mapping products and data sets to help corporate clients deploy marketing and sales efforts.


Tactician offers strategic market planning, solutions and services, sales territory planning, and targeted geomarketing solutions.

Leadspace Logo

Leadspace provides an Audience Management Platform which enables B2B companies to engage customers and drive growth by allowing marketers to find and know their audiences. As internal and external data multiplies, Leadspace uses AI to provide a source of truth across all sales and marketing data, identify net new account and individuals, and recommend the marketing activities.

Bombora Logo

Bombora is a global clearinghouse and provider of B2B demographic, firmographic and Intent data. Through its Data Co-op of B2B publishers, it has aggregated an unprecedented amount of B2B data at scale. This data is used by marketers, agencies, publishers and other B2B organizations to target and engage decision-makers and stakeholders as they endeavor to make purchasing decisions.


Allot is a commercial pharma analytics startup. It enables pharmaceutical and biotech companies to commercialize the drugs. It was founded in 2014 and is based in Essex, England.

Meplis Logo

Meplis provides an open patient health engagement platform and professional coordination through personalized education, guidance, and monitoring on web and mobile applications.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.